Company: BDRX
Filing Date: 2025-11-17
Form Type: POS AM
Source: 0001214659-25-016826
Chunk: 20

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: POS AM
Chunk 20
---
 number of our Ordinary Shares in excess of the beneficial ownership limitation. The amounts         
 and percentages in the table do not give effect to the 9.99% beneficial ownership limitation,       
 if applicable. The principal business address of Bigger Capital Fund, LP is 11700 West Charleston   
 Blvd, #170-659, Las Vegas, NV 89135.                                                                |

| (3) | The                                                                                                
 selling shareholder holds (i) warrants issued by us in prior transactions which entitle the        
 selling shareholder to purchase an aggregate of 393,900,000 Ordinary Shares (in the form           
 of Depositary Shares), and (ii) December 2023 Private Placement Pre-Funded Warrants, which         
 entitle the selling shareholder to purchase an aggregate of 90,600,000 Ordinary Shares (in         
 the form of Depositary Shares) and which we are registering hereby. The warrants are subject       
 to a beneficial ownership limitation of 9.99%, which does not permit the selling shareholder       
 to exercise that portion of the warrants that would result in the selling shareholder and          
 its affiliates owning, after exercise, a number of our Ordinary Shares in excess of the beneficial 
 ownership limitation. The amounts and percentages in the table do not give effect to the           
 9.99% beneficial ownership limitation, if applicable. The principal business address of District   
 2 Capital Fund LP is 14 Wall Street, 2nd Floor, Huntington, NY 11743.                              |

| 13 |

<div align='center'>DESCRIPTION OF OFFERED SECURITIES AND OUR SHARE CAPITAL</div>

The following describes our issued share capital, summarizes the material provisions of our Articles of Association and highlights certain differences in corporate law in the United Kingdom and the United States. This description of our share capital and summary of our Articles of Association is not complete, and is qualified by reference to our Articles of Association. You should read our Articles of Association, which are filed as an exhibit to the registration statement of which this prospectus forms a part, for the provisions that are important to you.

General

We are a public limited company
organized under the laws of England and Wales under registered number 09216368. Our registered office is 1 Caspian Point, Caspian Way,
Cardiff, CF10 4DQ, United Kingdom. The principal legislation under which we operate and our shares are issued is the Companies Act.

Our issued share capital
as of June 30, 2025 and November 1, 202